HUMANISIERTE ANTIKÖRPER GEGEN PSMA
European patent · EP3830132 · In force
Register entry
- Publication number
- EP3830132
- Application number
- EP19745146
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jul 30, 2019
- Published
- Jun 9, 2021
- Granted
- Nov 23, 2022
- Protection ends at the latest
- Jul 29, 2039
- Next annual fee due
- Jul 31, 2027
- IPC classes
- C07K 16/30 (2006.01)C07K 16/40 (2006.01)A61K 39/00 (2006.01)
- Priority
- EP 18186591 31.07.2018
- PCT application
- PCT/EP2019/070407 30.07.2019
- PCT publication
- WO2020/025564 06.02.2020
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Aug 1, 2026
Next annual fee due on
- Next annual fee due on
- 31.07.2026 → 31.07.2027
Published in Swissreg on 01.08.2026
- Aug 1, 2025
Next annual fee due on
- Next annual fee due on
- 31.07.2025 → 31.07.2026
Published in Swissreg on 01.08.2025
- Aug 5, 2024
Change
Published in Swissreg on 05.08.2024
- Oct 4, 2023
Change
Published in Swissreg on 04.10.2023
- Aug 1, 2023
Change
Published in Swissreg on 01.08.2023
- Nov 23, 2022
Granted
Published in Swissreg on 23.11.2022
Parties
Inventor
PAHL, Andreas
68526 Ladenburg, DE
HECHLER, Torsten
68526 Ladenburg, DE
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.